MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    The Transcriptome from Multiple Regions of the MPTP-induced Parkinson’s disease Mouse Brain after exercise

    T. Tong, Z. Zhang, Z. Zhang, H. Hu, L. Li, J. Jin (Shanghai, China)

    Objective: To illuminate the respective functions of substantia nigra, striatum, cortex and cerebellum in Parkinson's motor improvement following exercise training in a chronic MPD (MPTP…
  • MDS Virtual Congress 2021

    To Prescribe or Not to Prescribe: The impact of Parkinson’s nurse prescribers

    A. Hand, K. Mcewan, A. Clarke, K. Brittain, A. Bate, S. Dalkin, S. Mccarthy, R. Bradford, C. Allen, K. Mcdonald (Newcastle Upon Tyne, United Kingdom)

    Objective: After formal training, Parkinson’s Nurse Specialists (PNS) can act as independent and supplementary prescribers and initiate/titrate medication. This paper will discuss the impact of…
  • MDS Virtual Congress 2021

    Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database

    J. Bajwa, M. Salari, S. Khan, H. Amer, A. Al-Qassabi, A. Habib, J. Habib, M. Abu Al-Melh, M. Abu Snineh, Q. Un Nisa, S. Zaidi, A. Dahshan, W. Regragui, J. Ahmed, H. Shehata, I. Hashmat, N. Ullah Bullo, S. Om Mittal, T. Mohammad, W. Kamel, T. Houyam, S. Eljaffery, R. Rajan, M. Farghal, F. Abdulla, Z. Al-Daajani, P. Schmidt, H. Khalil (Riyadh, Saudi Arabia)

    Objective: To describe the development and organization of the Consortium for Global Diversity in Parkinson’s Disease (CDG-PD), created in 2020 with a broad aim to…
  • MDS Virtual Congress 2021

    Sleep disorders and future diagnosis of parkinsonism: a prospective study using the Canadian Longitudinal Study on Aging

    S. Zolfaghari, C. Yao, C. Wolfson, A. Pelletier, R. Postuma (Montreal, Canada)

    Objective: To determine whether symptoms of insomnia, somnolence, apnea, and restless legs syndrome predict the diagnosis of parkinsonism after three years of follow-up. Background: Earlier…
  • MDS Virtual Congress 2021

    Sociodemographic, cognitive, and clinical factors explaining financial-arithmetic errors in Parkinson’s Disease

    H. Loenneker, S. Becker, S. Nussbaum, H-C. Nuerk, I. Liepelt-Scarfone (Tuebingen, Germany)

    Objective: To assess the frequency, predictors, and affected cognitive representations of arithmetic errors in financial contexts in Parkinson’s Disease (PD), patients with normal cognition (PD-NC)…
  • MDS Virtual Congress 2021

    A prospective study of Parkinson’s disease progression towards dementia – dynamics and defining motor features

    T. Stojkovic, LJ. Ziropadja, E. Stefanova, V. Markovic, I. Stankovic, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: Our goal was to investigate the rate of progression to dementia (PDD) in our cohort of Parkinson’s disease (PD) patients and to explore how…
  • MDS Virtual Congress 2021

    SRY as a potential therapeutic target for men with Parkinson’s Disease

    V. Harley (Clayton, Australia)

    Objective: Develop a potential disease-modifying gene therapy for men with Parkinson’s Disease Background: A hallmark symptom of PD is the loss of midbrain dopamine (DA)…
  • MDS Virtual Congress 2021

    Clinical and genetic analysis of psychosis in Parkinson’s disease

    B. Radojević, N. Dragašević, A. Milovanović, V. Dobričić, M. Svetel, I. Petrović, M. Savić, I. Jančić, D. Stanisavljević, A. Marjanović, M. Branković, V. Kostić (Belgrade, Serbia)

    Objective: This study aimed to examine the association of seven selected polymorphisms of DRD2, ANKK1, COMT and DAT genes with Parkinson’s disease psychosis (PDP) onset.…
  • MDS Virtual Congress 2021

    Silencing of hypoxia-inducible factor 1 alpha provokes a neuroprotective response in a SH-SY5Y model of Parkinson’s Disease.

    S. Acharya, A. Lumley, C. Mebarki, V. Stopa, M. Vausort, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aims to delineate the role of HIF1α in a SH-SY5Y model of Parkinson’s disease (PD) Background: Parkinson’s disease (PD) is one of…
  • MDS Virtual Congress 2021

    Close relationship between CSF lipidomic alterations and cognitive decline in Parkinson’s disease.

    Y. Mizutani, S. Shima, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)

    Objective: To clarify what the lipidome of biological samples reflects in the pathology of Parkinson’s disease (PD). Background: The lipid pattern in the cerebrospinal fluid…
  • « Previous Page
  • 1
  • …
  • 422
  • 423
  • 424
  • 425
  • 426
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley